Document Detail


Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis.
MedLine Citation:
PMID:  10831977     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the correlation between the diagnosis of borderline tumor of the ovary by frozen and permanent pathology. METHODS: All pathology reports with diagnoses of borderline tumor of the ovary between 1980 and 1998 at Massachusetts General Hospital were reviewed. Univariate and multivariable logistic regression models were constructed for patient age, tumor size, histology, presence of bilateral or extraovarian disease, and concurrent diagnosis of endometriosis or endosalpingiosis. RESULTS: We reviewed 140 cases. The average age of patients was 52.3 years. Eighty tumors were serous, 47 mucinous, 11 mixed, and two endometrioid. The mean diameter overall was 13.7 cm (range 1-70 cm), 10.2 cm for serous, and 20.1 cm for mucinous. Diagnoses of borderline tumors by frozen and permanent pathology were consistent in 60% of cases. Frozen section interpreted a benign lesion as malignant (overdiagnosed) in 10.7% of cases, and interpreted a malignant lesion as benign (underdiagnosed) in 29.3%. No variable was a significant predicator of overdiagnosis. In univariate analysis, underdiagnosis was more likely for other types of tumors than serous (P <.001), tumors larger than 20 cm (P =.039), and tumors confined to the ovaries (P =. 009). When all variables were included in a multiple regression model, only histology was a significant predictor of underdiagnosis (P =.039). CONCLUSION: Frozen or permanent pathology reports of diagnoses of borderline tumor were consistent 60% of the time, whereas the positive predictive value of borderline by frozen section was 89.3%. Tumors other than serous are more likely to be misinterpreted.
Authors:
K Houck; N Nikrui; L Duska; Y Chang; A F Fuller; D Bell; A Goodman
Related Documents :
11860537 - Immunohistochemical localization of metallothionein in benign and malignant epithelial ...
12658347 - Histological classification of ovarian cancer.
19995707 - Mutations in the kras gene in ovarian tumors.
14716297 - A candidate tumor suppressor htra1 is downregulated in ovarian cancer.
12385007 - Three-dimensional fibroblast-tumor cell interaction causes downregulation of rack1 mrna...
21479457 - Deregulated expression of the per2 gene in human colorectal carcinoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  95     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-07-19     Completed Date:  2000-07-19     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  839-43     Citation Subset:  AIM; IM    
Affiliation:
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA. khouck@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / pathology*
Adenocarcinoma, Mucinous / pathology
Adolescent
Adult
Aged
Aged, 80 and over
Cystadenocarcinoma, Serous / pathology
Female
Frozen Sections*
Humans
Logistic Models
Middle Aged
Ovarian Neoplasms / pathology*
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes.
Next Document:  Prognostic nutritional index in relation to hospital stay in women with gynecologic cancer.